Scientific research now links certain high-fat, high-carbohydrate foods to brain changes that can raise your risk for obesity ...

Even though binge eating disorder is the most common eating disorder, two out of three adults would be unable to recognize ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

March 13 (Reuters) - Altimmune (ALT.O), opens new tab said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol ...

Obesity is a global health concern closely linked to a range of metabolic diseases, such as type 2 diabetes and ...

A team of Ohio University researchers have made a groundbreaking development in the fight against obesity. In a study ...

Opko Health and Entera Bio entered into a collaboration and license agreement to advance a tablet aimed at addressing obesity, metabolic and fibrotic disorders.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...